Biocryst Pharmaceuticals reported $1.86M in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
DBV Technologies DBVT:US 6.54M 1000
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Biocryst Pharmaceuticals BCRX:US $ 1.86M 0.01M
Chemocentryx CCXI:US $ 0.07M 0M
Chugai Pharma 4519:JP Y 73202M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Gilead Sciences GILD:US $ 1M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Mirati Therapeutics MRTX:US $ 0.06M 0M
Novavax NVAX:US $ 0.79M 0.02M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
YTE INCY:US $ 0.22M 0M